64 related articles for article (PubMed ID: 38503362)
1. Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria.
Arnous MG; Vaughan L; Mehta RA; Schulte PJ; Lieske JC; Milliner DS
J Urol; 2023 Jun; 209(6):1141-1150. PubMed ID: 36888927
[TBL] [Abstract][Full Text] [Related]
2. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs.
Huang Y; Zhu W; Zhou J; Huang Q; Zeng G
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785918
[TBL] [Abstract][Full Text] [Related]
3. Multiomics Assessment of the Gut Microbiome in Rare Hyperoxaluric Conditions.
Zaidan N; Wang C; Chen Z; Lieske JC; Milliner D; Seide B; Ho M; Li H; Ruggles KV; Modersitzki F; Goldfarb DS; Blaser M; Nazzal L
Kidney Int Rep; 2024 Jun; 9(6):1836-1848. PubMed ID: 38899198
[TBL] [Abstract][Full Text] [Related]
4. Oxalates: Dietary Oxalates and Kidney Inflammation: A Literature Review.
Karr T; Guptha LS; Bell K; Thenell J
Integr Med (Encinitas); 2024 May; 23(2):36-44. PubMed ID: 38911445
[TBL] [Abstract][Full Text] [Related]
5. A CASE OF RETINAL ATHEROSCLEROTIC OXALOSIS DUE TO HYPEROXALURIA IN A PATIENT WITH SHORT GUT SYNDROME.
Lee S; Malbin B; Alfaro C; Syeda S; Lin X
Retin Cases Brief Rep; 2024 Jul; 18(4):529-533. PubMed ID: 37104814
[TBL] [Abstract][Full Text] [Related]
6. Randomized Placebo-Controlled Trial of Reloxaliase in Enteric Hyperoxaluria.
Lieske JC; Lingeman JE; Ferraro PM; Wyatt CM; Tosone C; Kausz AT; Knauf F
NEJM Evid; 2022 Jul; 1(7):EVIDoa2100053. PubMed ID: 38319254
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and management of enteric hyperoxaluria.
Joly PF
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102359. PubMed ID: 38734370
[No Abstract] [Full Text] [Related]
8. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and management of enteric hyperoxaluria.
Desenclos J; Forté V; Clément C; Daudon M; Letavernier E
Clin Res Hepatol Gastroenterol; 2024 May; 48(5):102322. PubMed ID: 38503362
[TBL] [Abstract][Full Text] [Related]
10. The management of patients with enteric hyperoxaluria.
Asplin JR
Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
[TBL] [Abstract][Full Text] [Related]
11. Enteric hyperoxaluria: role of microbiota and antibiotics.
Liu M; Nazzal L
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):352-359. PubMed ID: 31145706
[TBL] [Abstract][Full Text] [Related]
12. Enteric and mild hyperoxaluria.
Sutton RA; Walker VR
Miner Electrolyte Metab; 1994; 20(6):352-60. PubMed ID: 7783697
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and Treatment of Enteric Hyperoxaluria.
Witting C; Langman CB; Assimos D; Baum MA; Kausz A; Milliner D; Tasian G; Worcester E; Allain M; West M; Knauf F; Lieske JC
Clin J Am Soc Nephrol; 2021 Mar; 16(3):487-495. PubMed ID: 32900691
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
